PMA-31638-87198 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Dose 1 — Pfizer-BioNTech
2021-01-08
Dose 2 — Pfizer-BioNTech
2021-02-23
Registered in v-safe
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-09
Dose 3 — Pfizer-BioNTech
2021-09-29
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-02
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-09
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-03-10
Survey response — 6 months, dose 3
MedDRA: Pre-existing disease, Sinusitis — Feeling: Good

Free text: Seasonal allergies and sinus infection

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-08	Pfizer-BioNTech
3	2021-09-09	Pfizer-BioNTech	No

Free text

Release 11 — 6 months, dose 3

2022-03-10

Symptoms: Seasonal allergies and sinus infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pre-existing disease	·	·	✓
SD	Sinusitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release